Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Vaccine development

    - PMLiVE

    MHRA marks 100 years of patient safety through biological standards

    The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

    - PMLiVE

    Lilly and WHO Foundation partner to support global dementia action plan

    The partnership will provide financial support and strengthen early detection and intervention efforts

    - PMLiVE

    University of Liverpool identifies new class of antibiotic in fight against AMR

    The new antibiotic class targets two of the WHO’s ‘priority pathogens’

    - PMLiVE

    UKHSA releases list of pathogens posing ‘greatest risk’ to public health

    The agency has listed 24 pathogen families where preparedness efforts are most needed

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    Valneva and LimmaTech Biologics partner to advance Shigella vaccine candidate

    There is currently no vaccine approved for Shigella, the second leading cause of fatal diarrhoeal disease globally

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    WHO and CEPI call for broader research strategy to prepare for future pandemics

    They have highlighted the importance of expanding research to entire families of pathogens

    - PMLiVE

    GSK and Flagship Pioneering partner in deal worth up to $7bn to discover medicines and vaccines

    The companies aim to develop a portfolio of up to ten candidates

    - PMLiVE

    WHO calls for better medicines access to close neurological disorders treatment gap

    In 2021, neurological conditions affected more than three billion people worldwide

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links